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Abstract
Background: It is well known that the presence of population stratification (PS) may cause the usual test in case-
control studies to produce spurious gene-disease associations. However, the impact of the PS and sample selection
(SS) is less known. In this paper, we provide a systematic study of the joint effect of PS and SS under a more
general risk model containing genetic and environmental factors. We provide simulation results to show the
magnitude of the bias and its impact on type I error rate of the usual chi-square test under a wide range of PS
level and selection bias.
Results: The biases to the estimation of main and interaction effect are quantified and then their bounds derived.
The estimated bounds can be used to compute conservative p-values for the association test. If the conservative p-
value is smaller than the significance level, we can safely claim that the association test is significant regardless of
the presence of PS or not, or if there is any selection bias. We also identify conditions for the null bias. The bias
depends on the allele frequencies, exposure rates, gene-environment odds ratios and disease risks across
subpopulations and the sampling of the cases and controls.
Conclusion: Our results show that the bias cannot be ignored even the case and control data were matched in
ethnicity. A real example is given to illustrate application of the conservative p-value. These results are useful to the
genetic association studies of main and interaction effects.
Background
In the search of causative agents of human disease, both
environmental and genetic risk factors have been identi-
fied. Overwhelming evidence indicates that there are
reasons to believe that relative common polymorphisms
in a wide spectrum of genes may modify the effect of
environmental agents [1,2]. Several studies also have
demonstrated the presence of gene-gene interaction in
complex human diseases [3-7]. Gene-gene interaction,
or epistasis, is also considered as a basic genetic concept
which has been widely used by biologists for a long time
[8].
Many association designs have been proposed for
studying gene-environment or gene-gene interactions.
Recently, Wang and Zhao [9] found that in the study of
gene-gene interactions, the unmatched case-control
association design is more powerful than both the
matched case-control design and case-parents design.
They also found that when a logistic regression model is
fitted for assessing gene-environment interactions based
on case-parents sample, the approach may be suscepti-
ble to the PS bias [10]. However, case-control design is
also well known to be susceptible to the PS bias in the
study of genetic effect, if the gene under study shows
marked variation in allele frequency across subgroups of
the population and if these subgroups also differ in their
base-line disease risks [11-17]. Wang, et al. [18] recently
provided numerical examples showing that when the
correlation between genetic and environmental factors is
small or the linkage disequilibrium is weak, and case-
control data were collected according to a simple ran-
dom sampling (SRS) scheme, that is no selection bias,
the PS bias in testing null interaction odds ratio is also
small. However, selection bias often occurs in case-
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better understand the impact of the PS and SS.
In this paper, we investigate the joint effect of population
stratification and sample selection in testing null main or
interaction effects. Under general sampling, we quantify
the magnitude of the PS-SS bias in terms of the baseline
disease risks, genotype frequencies, exposure rates, their
odds ratios (linkage disequilibrium coefficients), and the
effect sizes of the risk factors. Based on this result, we find
that matching in ethnicity cannot eliminate bias in associa-
tion studies. Using the bias, we are also able to derive
important conditions under which it is null.
The PS-SS bias cannot be estimated, since we don’t
know how many subpopulations involved in the studied
population and/or which subpopulation a person belongs
to. Although adjusting for covariates such as principal
components can be used to account for PS in genome
wide association studies [19], however, it is not clear
whether the same approach can be applied in the studies
of interaction. Since, for example, the bias level also
depends on the effect size of the environmental factor. In
this paper, we also derive useful bounds to measure the
maximal impact of the bias. Sometimes, these bounds
can be estimated so that tests robust to the joint effect of
PS and SS can be derived; see Lee and Wang [20] for
similar suggestion in studies of gene-disease association.
We use theoretical formula and simulation results to
show the general properties of the usual association test
in the presence of PS or selection bias. We also provide a
real example to demonstrate computation of a conserva-
tive p-value in studying interaction effect of maternal
smoking and GSTT1 variant on the risk of orofacial cleft.
Results
The Magnitude of the Bias
We begin this section with the notation that will be
used throughout this work. Disease status is denoted as
D with levels D = 1, and 0, indicating the presence and
absence of the disease, respectively. Let G =1 ( 0 )r e p r e -
sent the presence (absence) of the genotype of interest.
H = 1(0) represents the presence (absence) of the envir-
onmental exposure or another genotype of interest.
Although we only focus on 2 × 2 × 2 table, however, all
results can be extended to any number of risk factors or
any number of levels. We also assume that the popula-
tion under study consists of K subpopulations and
denote S as the stratification variable, taking values s =
1,..., K. However, K is unknown and S is not observable
in our discussion of the PS effect.
To quantify the PS effect, we assume that the risk
model is given by
logit P(D =1|G = g,H = h,S = s)
= μ  + α 
s + βg + γh + δgh,
where the genetic and environmental data are
obtained from subpopulation s. As usual, we use s =1 ,g
=0 ,a n dh = 0 to represent the referent subpopulation,
genotype and environmental exposure, respectively. For
the purpose of identifiability, we define α 
1 =0 .α 
s,s =
1,..., K, are the subpopulation-specific parameters repre-
senting the potential heterogeneity of disease risk across
subpopulations. In this model, log-odds-ratio b mea-
sures the association between the genotype and risk of
disease, log-odds-ratio g measures the association
between the environmental exposure (or another geno-
type) and risk of disease. The multiplicative interaction
δ measures the change of the disease-genotype log-
odds-ratios according to different levels of risk factor H.
Similar risk models for studying genetic effect under PS
can be found in Satten et al. [21] and Cheng and Lin
[17], for examples. For subpopulation s,w eu s eORs to
represent the baseline G-H odds ratio (given D =0 ) .
Define
Gs =
P(G =1 |S = s,D =0 ,H =0 )
P(G =0 |S = s,D =0 ,H =0 )
as the baseline G- frequency odds and baseline H- fre-
quency odds Hs is similarly defined. Also define Ds as
the baseline disease frequency odds given by
Ds =
P(D =1 |S = s,G =0 ,H =0 )
P(D =0 |S = s,G =0 ,H =0 )
.
In the discussion of PS effect, one often assumes
that case and control data are sampled according to
the SRS design. Let P(S=s | D=1) and P(S=s | D=0)
represent the corresponding proportions of subpopula-
tion s in the cases and controls, respectively. However,
in real applications, selection bias often happens and
sampling may not be done according to the SRS
scheme for various reasons. Let the true proportion of
subjects in the cases (controls) that are from subpopu-
lation s be denoted by P
#(S=s | D=1) (P
#(S=s | D=
0)). We use DSs =
P# (S = s|D =1 )
P(S = s|D =1 )
/
P# (S = s|D =0 )
P(S = s|D =0 )
to
measure the effect of the sample selection for subpo-
pulation s. If there is no selection bias, DSs =1 .
S i n c ei nt h ep o p u l a t i o nl e v e lw eo n l yo b s e r v ef a c t o r s
G and H, we show in the Methods section that given
t h ep r e s e n c eo fP Sa n dg e n e r a ls a m p l i n g ,t h em a i n
effects and interaction are given by
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Page 2 of 10D − G odds ratio = exp

β + β∗
,
D − H odds ratio = exp

γ + γ ∗
,
G × H interaction = exp

δ + δ∗
,
where
β∗ =l o g

K(1,0)
K(0,0)

,
γ ∗ =l o g

K(0,1)
K(0,0)

,
δ∗ =l o g

K(1,1)K(0,0)
K(1,0)K(0,1)

,
and
K(g,h)=
[
K 
s=1

P(G =0 ,H =0 |S = s,D =0 )

×
	
P#(S = s|D =0 ) OR
g×h
s G
g
sHh
s DsDSs


]÷
[
K 
s=1

P(G =0 ,H =0 |S = s,D =0 )

×
	
P#(S = s|D =0 ) OR
g×h
s G
g
sHh
s


].
exp(b*), exp(g*) and exp(δ*) are the bias levels. We
note that if DsDSs is a constant with respect to s, then K
(g, h)is also a constant and there is no bias of any kind.
A sufficient condition for this to hold is when the base-
line disease risk is identical across all subpopulations
and sampling of the study follows a SRS design. Further,
since
DsDSs =
P# (S = s|D =1 )
P# (S = s|D =0 )
×
P(D =0 |S = s)
P(D =1 |S = s)
×
P(D =1 |G = H =0 ,S = s)
P(D =0 |G = H =0 ,S = s)
×
P(D =1 )
P(D =0 )
,
therefore, if the disease prevalence P(D=1|S = s)a n d
baseline disease risk P(D=1|G = H = 0,S=s )a r e
approximately equal in each subpopulation, then bias
depends on DsDSs only through the degree of matching
P# (S = s|D =1 )
P# (S = s|D =0 )
. Accordingly, if the case and control
are matched in ethnicity, then the bias should be very
small. However, P(D=1|S = s) ≈ P(D=1|G = H = 0,S
=s ) for all subpopulations is often not true when envir-
onmental factor, such as smoking, are involved in caus-
ing the disease risk. Under this scenario, even the cases
and controls are perfectly matched, the bias can still be
large. This conclusion is different from that under the
gene-disease association study; see for example, Cheng,
Lee and Chen [22]. We shall see more discussion of this
issue in latter sections.
Maximal bias and conditions for the null bias
Here, we give conditions for the null bias and bounds
for bias. The bias exp(b*) to the estimation of genetic
main effect depends on the variation of the genotype
frequencies measured byG† =m a x
s
Gs/min
s Gs,variation
of the disease prevalence measured by
D† =m a x
s
Ds/min
s Dsand the sampling variation mea-
sured by DS† =m a x
s
DSs/min
s DSs. The bias exp(δ*) to
the estimation of interaction depends additionally on
the variation of the baseline odds ratio, measured by
OR† =m a x
s
ORs/min
s ORs and the variation of exposure
rates measured by H† =m a x Hs
s
/min
s Hs.
Note that the bias b* depends only on K(g, 0). We first
present some conditions for the null bias b*=0 ,w h e n
the true genetic main effect is null: (1) if the baseline
genotype frequency is constant across subpopulations,
then the bias b* is zero (can be proved using equation
(1) in the Methods section); (2) if the sample selection
follows a SRS scheme (DS
† =1 ) ,a n dt h ed i s e a s er i s ki s
constant, then the bias is also null. (However, if the
sampling is not SRS, the bias may be non-null; see
Tables 1 and 2.); (3) if the case and control data are
matched in ethnicity, and g = δ = 0 (both H-main effect
and interaction are null), then the bias is null.
When the interaction effect is null, some conditions
for the null bias δ* = 0 are: (1) if the baseline G-H odds
ratios and G(or H)- frequency odds are constant across
subpopulations, then the bias δ* is null (can be proved
using equation (2) in the Methods section); (2) if the
sample selection of the study follows SRS, and the dis-
ease risk is constant, then the bias δ*i sa l s on u l l .H o w -
ever, see Tables 1 and 2 for the presence of bias when
the SRS condition fails.
Next, we present bound to measure the largest bias to
the estimation of main effect. In the Methods section,
we show that the bias exp(b*) can be expressed as
exp(β∗)=
K 
s=1
Gs {DsDSs}ws
K 
s=1
Gsws
K 
s=1
{DsDSs}ws
≤
√
G†D†DS†
√
G†D†DS† +1

2
√
G†D†DS† + G†

√
G†D†DS† + D†DS†


≡ Uβ,
(1)
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K 
s=1
ws =1. The bias is the greatest when the number of
subpopulations is 2. The bias is also bounded below
byLβ ≡ U−1
β . These bounds give the maximal impact of
the bias in making inference about the genetic main
effect. Under rare disease, the background disease rate is
approximately equal to the background disease odds.
We find that the bound under SRS (DS
† = 1) is similar
to that given by Lee and Wang [19]. However, our result
is more general in the sense that their risk model was a
special case of ours and selection bias was not consid-
ered in their paper either.
In the Methods section, we also showed that under
SRS, the bias exp(δ*) was bounded above by U
(1)
δ =(D
† )
2 and bounded belowL
(1)
δ =(D
† )
-2. These are the same
bounds derived by Wang et al. [18]. Unfortunately,
these bounds are not valid when there is selection bias.
Under the general sample selection, we showed that the
bias exp(δ*) was bounded above by
Table 1 Biases and the true type I errors of the chi-square tests when G
† = 5 and LD = (0,0)
Bias
(g =0 )
type I error
(g =0 )
Bias
(g =1 )
type I error
(g =1 )
H
† D
† DS
† |b*| | δ*| ab aδ |b*| | δ*| ab aδ
1 1 1 0.0000 0.0000 0.0500 0.0500 0.0000 0.0000 0.0500 0.0500
3 0.2365 0.0000 0.3815 0.0500 0.2365 0.0000 0.3412 0.0500
5 0.2975 0.0000 0.5513 0.0500 0.2975 0.0000 0.4970 0.0500
PM 0.0000 0.0000 0.0500 0.0500 0.0000 0.0000 0.0500 0.0500
3 1 0.3725 0.0000 0.7134 0.0500 0.3725 0.0000 0.6530 0.0500
3 0.5953 0.0000 0.9823 0.0500 0.5953 0.0000 0.9661 0.0500
5 0.6518 0.0000 0.9937 0.0500 0.6518 0.0000 0.9857 0.0500
PM 0.0000 0.0000 0.0500 0.0500 0.0000 0.0000 0.0500 0.0500
5 1 0.5573 0.0000 0.9602 0.0500 0.5573 0.0000 0.9326 0.0500
3 0.7679 0.0000 0.9993 0.0500 0.7679 0.0000 0.9977 0.0500
5 0.8205 0.0000 0.9998 0.0500 0.8205 0.0000 0.9992 0.0500
PM 0.0000 0.0000 0.0500 0.0500 0.0000 0.0000 0.0500 0.0500
3 1 1 0.0000 0.0000 0.0500 0.0500 0.0000 0.0000 0.0500 0.0500
3 0.1916 0.1548 0.2583 0.0796 0.1916 0.1548 0.2232 0.0830
5 0.2383 0.2157 0.3729 0.1074 0.2383 0.2157 0.3201 0.1139
PM 0.0000 0.0000 0.0500 0.0500 0.0660 0.0285 0.0688 0.0511
3 1 0.3342 0.0762 0.5794 0.0572 0.3310 0.0796 0.4827 0.0584
3 0.5134 0.2312 0.9209 0.1163 0.5071 0.2345 0.8439 0.1232
5 0.5564 0.2892 0.9559 0.1538 0.5493 0.2918 0.8971 0.1632
PM 0.0000 0.0000 0.0500 0.0500 0.0930 0.0073 0.0812 0.0501
5 1 0.5129 0.0683 0.8997 0.0557 0.5058 0.0776 0.8083 0.0577
3 0.6812 0.2225 0.9918 0.1104 0.6687 0.2311 0.9657 0.1187
5 0.7210 0.2779 0.9962 0.1442 0.7071 0.2852 0.9796 0.1546
PM 0.0000 0.0000 0.0500 0.0500 0.0957 0.0222 0.0799 0.0506
5 1 1 0.0000 0.0000 0.0500 0.0500 0.0000 0.0000 0.0500 0.0500
3 0.1608 0.2158 0.1912 0.1113 0.1608 0.2158 0.1639 0.1164
5 0.1986 0.3042 0.2693 0.1720 0.1986 0.3042 0.2270 0.1816
PM 0.0000 0.0000 0.0500 0.0500 0.0884 0.0532 0.0815 0.0541
3 1 0.3005 0.1007 0.4697 0.0635 0.2951 0.1081 0.3676 0.0659
3 0.4501 0.3178 0.8213 0.1855 0.4405 0.3252 0.6897 0.1942
5 0.4848 0.4026 0.8762 0.2656 0.4741 0.4085 0.7551 0.2750
PM 0.0000 0.0000 0.0500 0.0500 0.1325 0.0192 0.1063 0.0505
5 1 0.4702 0.0892 0.8176 0.0605 0.4574 0.1089 0.6735 0.0655
3 0.6101 0.3062 0.9661 0.1738 0.5901 0.3249 0.8820 0.1880
5 0.6423 0.3875 0.9794 0.2470 0.6203 0.4034 0.9122 0.2609
PM 0.0000 0.0000 0.0500 0.0500 0.1409 0.0474 0.1064 0.0529
PM means that perfect matching P
#(S = s|D =1 )=P
#(S = s|D = 0) is satisfied.
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√
G†H† +1

3
√
G†H† + G†

√
G†H† + H†

×
√
G†H† + G†H†


√
G† +
√
H†

2 ≡ U
(2)
δ ,
(2)
and bounded below by 1/U
(2)
δ ≡ L
(2)
δ .U s i n gt h e s e
bounds we can easily conclude that if the genetic factors
are in linkage equilibrium within each subpopulation,
and the variation of the G (or H) frequency odds is
small then the bias is also expected to be small.
True type I errors
In case-control studies, one often expects that the type I
errors of the association tests can be approximately con-
trolled at some predetermined level. However, in the
presence of PS or selection bias, the usual test statistic
does not have a chi-square distribution under the null
hypothesis. Instead, it has a non-central chi-square dis-
tribution, with non-centrality parameter depending on
Table 2 Biases and true type I errors of the chi-square tests when G
† = 5 and LD = (0,0.05)
Bias
(g =0 )
type I error
(g =0 )
Bias
(g =1 )
type I error
(g =1 )
H
† D
† DS
† |b*| | δ*| ab aδ |b*| | δ*| ab aδ
1 1 1 0.0000 0.0000 0.0500 0.0500 0.0000 0.0000 0.0500 0.0500
3 0.1862 0.3173 0.2456 0.1731 0.1862 0.3173 0.2116 0.1886
5 0.2313 0.4242 0.3535 0.2709 0.2313 0.4242 0.3021 0.2976
PM 0.0000 0.0000 0.0500 0.0500 0.0710 0.0871 0.0715 0.0598
3 1 0.3288 0.3309 0.5611 0.1735 0.3281 0.3208 0.4722 0.1791
3 0.5028 0.6401 0.9076 0.5019 0.5014 0.6166 0.8324 0.5127
5 0.5443 0.7413 0.9463 0.6209 0.5427 0.7122 0.8873 0.6299
PM 0.0000 0.0000 0.0500 0.0500 0.0972 0.0634 0.0837 0.0543
5 1 0.5062 0.4591 0.8883 0.2776 0.5046 0.4356 0.8052 0.2784
3 0.6695 0.7603 0.9894 0.6206 0.6667 0.7132 0.9643 0.6110
5 0.7080 0.8563 0.9948 0.7207 0.7048 0.8001 0.9787 0.7072
PM 0.0000 0.0000 0.0500 0.0500 0.0971 0.0486 0.0806 0.0523
3 1 1 0.0000 0.0000 0.0500 0.0500 0.0000 0.0000 0.0500 0.0500
3 0.1365 0.4049 0.1484 0.2659 0.1365 0.4049 0.1278 0.2821
5 0.1677 0.5542 0.2022 0.4417 0.1677 0.5542 0.1700 0.4669
PM 0.0000 0.0000 0.0500 0.0500 0.0961 0.1592 0.0851 0.0842
3 1 0.2693 0.3457 0.3779 0.1993 0.2634 0.3503 0.2862 0.2072
3 0.3958 0.7451 0.6991 0.6654 0.3859 0.7440 0.5461 0.6719
5 0.4244 0.8876 0.7629 0.8067 0.4135 0.8823 0.6072 0.8083
PM 0.0000 0.0000 0.0500 0.0500 0.1517 0.0739 0.1175 0.0561
5 1 0.4286 0.4464 0.7192 0.2912 0.4138 0.4620 0.5509 0.3090
3 0.5465 0.8394 0.9110 0.7501 0.5248 0.8442 0.7650 0.7536
5 0.5730 0.9756 0.9361 0.8607 0.5495 0.9731 0.8041 0.8575
PM 0.0000 0.0000 0.0500 0.0500 0.1656 0.0311 0.1203 0.0510
5 1 1 0.0000 0.0000 0.0500 0.0500 0.0000 0.0000 0.0500 0.0500
3 0.1034 0.4594 0.1039 0.3341 0.1034 0.4594 0.0917 0.3479
5 0.1262 0.6322 0.1325 0.5520 0.1262 0.6322 0.1135 0.5712
PM 0.0000 0.0000 0.0500 0.0500 0.0942 0.2098 0.0812 0.1101
3 1 0.2198 0.3865 0.2562 0.2424 0.2106 0.4008 0.1850 0.2529
3 0.3151 0.8406 0.4848 0.7777 0.3007 0.8531 0.3371 0.7791
5 0.3360 1.0059 0.5407 0.8992 0.3203 1.0147 0.3769 0.8962
PM 0.0000 0.0000 0.0500 0.0500 0.1623 0.0942 0.1176 0.0597
5 1 0.3590 0.4966 0.5345 0.3548 0.3343 0.5395 0.3535 0.3893
3 0.4474 0.9442 0.7431 0.8503 0.4139 0.9825 0.5114 0.8572
5 0.4667 1.1027 0.7822 0.9352 0.4310 1.1341 0.5467 0.9344
PM 0.0000 0.0000 0.0500 0.0500 0.1859 0.0365 0.1256 0.0513
PM means that perfect matching P
#(S = s|D =1 )=P
#(S = s|D = 0) is satisfied.
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tends to have inflated type I errors.
Suppose that the intended type I error rate of the chi-
square test is a and let χ2
1;1−αrepresent the 100(1-a)
percentile of the chi-square distribution with one degree
of freedom. Let χ2
1( ) represent a non-central chi-
square random variable with one degree of freedom and
non-centrality parameter Δ. In the case of testing null
interaction, the non-centrality parameter is given by
 δ =

δ∗2 ÷

1
n
(1)
11
+
1
n
(1)
01
+
1
n
(1)
10
+
1
n
(1)
00

+
+

1
n
(0)
11
+
1
n
(0)
01
+
1
n
(0)
10
+
1
n
(0)
00

,
where n
(d)
gh is number of observations with outcome G
=g , H=hand disease status d. Then the true type I
error of the usual chi-square test of null interaction is
given by αδ = P(χ2
1( δ) ≥ χ2
1;1−α), which is always ≥ a.
In the case of testing null genetic main effect, the non-
centrality parameter is given by
 β =
{β∗}2
(
1
n
(1)
10
+
1
n
(1)
00
+
1
n
(0)
10
+
1
n
(0)
00
)
.
The corresponding true type I error of the chi-square
test is given by αβ = P(χ2
1( β) ≥ χ2
1;1−α), which is also
≥ a.
Conservative p-values
In most practical applications, one often does not know
t h et r u ev a l u eo ft h en o n - c entrality parameter and
therefore it is difficult to calculate the true p-value of
the chi-square test when the PS is present and/or there
is selection bias. However, we are able to develop a
bound for the non-centrality parameter, and the latter
may be estimable in many cases. Define  ∗
δ ( ∗
β)a s
Δδ(Δb)b u tw i t hδ*( b*) replaced by its upper bound
logU
(2)
δ (logUb). Let χ2
δ (χ2
β ) be the usual statistic for
testing null interaction (main effect). Then following
Cheng, Lee and Chen [22], a conservative p-value of the
chi-square test is given by P(χ2
1( ∗
δ) ≥ χ2
δ )
(P(χ2
1( ∗
β) ≥ χ2
β)). We note that by using the property
of non-central chi-square distribution, the test based on
u s i n gc o n s e r v a t i v ep - v a l u ea l w a y sh a v et r u et y p eIe r r o r
rate smaller than or equal to the significance level and
the latter is always smaller than or equal to the true
type I error rate of the usual chi-square test. If a test
has conservative p-value less than or equal to the desig-
nated significance level, it is significant even there is PS
or selection bias.
Examples of true biases and type I error rates
Tables 1 and 2 show some values of the biases b* and δ*
and true type I error rates ab and aδ of the usual chi-
square tests when the significance level is 0.05. We
assumed that there are two subpopulations (K =2 ) ,b =
δ = 0, g = 0o r1 .G (H-) frequency of the first subpopu-
lation was given by P(G =1 |S = 1) = 0.51 (P(H =1 |S =
1) = 0.19), the first subpopulation disease risk was P(D
=1 |S = 1) = 0.05, the proportion of subpopulation 1 in
the overall population was 0.7, and case and control
sample sizes both equaled to n = 500. We defined LDs =
(LD1, LD2)w h e r eLDs was the linkage disequilibrium
coefficient between loci G and H in subpopulation s,
a n dc o n s i d e r e dl i n k a g ed i s e quilibrium coefficient LDs =
0 or 0.05. We also assumed that the sampling propor-
tions of the cases followed SRS but those of the controls
might not. The rest of the parameter values were deter-
mined from the values for the variations G
† ,H
† ,D
† and
DS
† given in the tables with the assumption that subpo-
pulation 2 has the maximal baseline G (or H) frequency
odds, disease risk, and sampling deviation (this implies
that P
#(S =2 |D = 0) ranges from 0.0585 to o.7163).
F i n a l l y ,w en o t et h a ti nc o m p u t i n gt h en o n - c e n t r a l i t y
parameters, the sample frequencies nd
gh were replaced
by n × P(G=g , H=h | D=d ). The simulation results
for G
† =5w e r eg i v e ni nT a b l e s1a n d2 ,a n dt h o s ef o r
G
† = 3 can be found from Tables S1 and S2 in Addi-
tional file 1.
According to the results in Table 1 the true type I
error ab ranges from 0.05 to 0.9998 under linkage equi-
librium. If the SRS condition holds and g = 0, the true
type I error ab ranges from 0.05 to 0.9602 with mean
0.4377 and standard error 0.3298. Under the same con-
ditions but g = 1, the corresponding range becomes
(0.05, 0.9326) with mean 0.3822 and standard error
0.2969. On the other hand, if the sampling is not SRS
(DS
† =3o r5 )a n dg = 0, the range of ab is (0.05,
0.9998) with mean 0.6871 and standard error 0.317.
Under non-SRS but g = 1, the corresponding range
becomes (0.05, 0.9992) with mean 0.6291 and standard
error 0.3117. These results indicate that the bias can be
quite large and its level may be modified by the sample
selection and the level of H-main effect. We also
observe that the bias b* may be nonzero under perfect
matching. For example, if matching is perfect and H-
main effect g = 1, the largest true type I error is 0.1064,
which occurs at the case with G
† = H
† =D
† = 5. This is
contrary to our usual belief that matching between cases
and controls in ethnicity can eliminate the PS bias.
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perfect matching design are smaller than those under
other sampling designs.
Wang et al. [18] suggested that the bias δ*t ot h e
interaction effect is small when the linkage disequili-
brium coefficient is small and the sampling is SRS. Our
Table 1 also shows that under the same condition, the
true type I error aδ in testing null interaction ranges
from 0.05 to 0.0659. This agrees with their finding.
However, if there is selection bias (DS
† =3o r5 ) ,t h e
true type I error rate aδ has range (0.05, 0.2656), mean
0.101, and standard error 0.056 when g = 0, and range
(0.05, 0.2750), mean 0.1053, and standard error 0.0597
when g = 1. The means and standard errors given here
and later were computed based on the results shown in
Tables 1 and 2, and Tables S1 and S2 in Additional file
1. These results indicate that PS and SS also can cause
serious bias problem in case-control study of gene-gene
interactions even when the two genes are in linkage
equilibrium. Under this scenario, the best way of redu-
cing the bias is to match cases and controls in ethnicity.
We note that under perfect matching and linkage equili-
brium, the range of aδ is only between 0.05, and 0.0541.
Linkage disequilibrium between two genes or correla-
tion between genetic and environmental factors play
important role in determining the bias level in the stu-
dies of interaction. According to results presented in
Table 2 we find that the bias to the estimation of the
genetic main effect becomes smaller when the linkage
disequilibrium coefficient increases from 0 to 0.05.
When g = 0, the mean of ab is 0.3377 under SRS and
0.5514 under non-SRS (selection bias), and when g = 1
the mean becomes 0.2716 and 0.4597, under SRS and
non-SRS, respectively. On the contrary, the bias to the
estimation of the interaction effect increases when the
linkage disequilibrium coefficient increases from 0 to
0.05. Our results show that when g = 0, the mean of aδ
is 0.1642 under SRS and 0.5512 under non-SRS. When g
= 1, the mean becomes 0.1706 and 0.5555, under SRS
and non-SRS, respectively. In all, bias δ* seems to
become larger when linkage disequilibrium coefficient
gets larger. Under stronger linkage disequilibrium, the
true type I error aδ can be as large as 0.1101 even the
cases and control were perfectly matched.
An application
Shi et al. [23] studied the interaction effects of maternal
smoking and maternal or fetal pharmacogenetic variants
on the risk of orofacial cleft based on 1244 subjects
from Demark and Iowa, USA with facial clefting and
4183 parents, siblings or unrelated population controls.
We considered the combined Denmark and Iowa case-
control data with H = 1if maternal smoking was yes (0
if no) and G = 1if GSTT1 genotype was null (0, if
genotype was not-null); see Table A6 of [23]. Based on
these data, we found that G × H interaction was 3.2499
and chi-square test had p-value equal to 5.5676 × 10
-4,
indicating strong interaction effect. Also, from [24] we
found that GSTT1 genotype frequencies of the Cauca-
sian populations were between 0.129 and 0.276, giving
the variation of the genotype frequencies G
† = 4.8762.
The range of maternal smoking rate was between 0.101
and 0.244 (see [25-27]), giving the variation of exposure
rates H
† = 1.968. Since maternal smoking and GSTT1
were independent in the unrelated control population
(p-values of the independence test for the Demark data
and Iowa data were respectively equal to 0.0942 and
0.0976), our upper bound for the bias exp(δ*) (see equa-
tion 2) equals to 1.6149, leading to the conservative p-
value equal to 2.0353 × 10
-2. This suggests that the
maternal smoking effect on the cleft risk can be modi-
fied by the GSTT1 genotype even the population strati-
fication and selection bias are both present in the study.
Discussion
The impact of population stratification is considered by
many to be important in case-control studies of gene-
disease association. Many authors have suggested quan-
titative methods to control type I errors of the usual
association test. The most popular treatments include
the “genomic control” method [28-33] and the “struc-
tured association” method [34-37]. Each of the proposed
methods requires typing extra polymorphic markers to
generate an estimate of PS which can be used to adjust
the test statistic. The impact of PS in case-control stu-
dies of gene-gene (environment) interaction is consid-
ered to be less important, when the genes under studied
are in linkage equilibrium or when the gene-environ-
ment correlation is weak [18,38]. However, this conclu-
sion holds only when the sampling of the case and
control data follow a SRS design, that is no selection
bias. Unfortunately, there is no formal method for test-
ing the validity of the SRS condition when the PS is
present.
In practical applications, the selection bias is not unu-
sual. For examples, when the hospital-based cases (con-
trols) are used in the study and they are not
representative of the population-based cases (controls)
or when many non-response of the cases or/and con-
trols occur in the study or there are self-selections, then
the SRS condition may fail. In this paper, we show that
under slight selection bias (DS
† = 3), the bias to the esti-
mation of main or interaction effect may become unac-
ceptable. Our suggestion is that the bias should be
treated seriously, even when the genetic factors are in
linkage equilibrium or the genetic and environmental
factors are uncorrelated. Large correlation or strong
linkage disequilibrium could make the bias become even
Cheng and Lee BMC Genetics 2012, 13:5
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antee small bias, unless there is also small selection bias.
In applications, it is important to be able to measure the
impact of the bias. In this paper, we drive some bounds
for the bias. If these bounds are estimable, then they
can be used to make conservative inference. We show
one real example that a conservative p-value for testing
null interaction can be computed and significance con-
clusion can be reached even there is bias. Genotype fre-
quencies of the SNPs and their LDs are readily available
from international HapMap project. Further, disease
prevalence is also available from many nations or from
World Health Organization, for example. This informa-
tion allows us to easily compute bounds and then con-
servative p-values.
We note that matching in ethnicity between cases and
controls has been suggested by epidemiologists as an
affective method to control the PS bias in case-control
gene-disease association study. However, in a more
complicated risk model such as the one discussed here,
bias (b*) (see equation 1) to the genetic main effect also
depends on the effect size of other risk factor. We
found that if g = δ = 0 then the residual bias after
matching is small. However, if g = 1, and δ = 0, the resi-
dual bias after matching is still quite substantial. A suffi-
cient condition to assure bias b*=0u n d e rp e r f e c t
matching is g = δ = 0 .T a b l e s1a n d2a l s os h o wt h a t
matching cannot remove bias to the estimation of the
interaction effect.
Since the presence of PS and selection bias may cause
unacceptable bias to the usual interaction analysis, it is
of importance to have an efficient method to control
the bias. Unfortunately, so far there exists no effective
method. The major difficulty is that the level of the bias
depends on the effect size of other related factor which
is in general unknown or not estimable under the PS.
However, under some special cases, for example, when
the genetic main effects are null (or weak) and testing
gene-gene interaction is the main focus, one may follow
the idea of genomic control to type extra pairs of null
markers and apply the computed interaction levels to
control the bias. In principle, if the candidate markers
are in linkage equilibrium, the selected pairs of null
markers also need to be in linkage equilibrium so that
the important characteristics of the bias can be cap-
tured. On the other hand, if the candidate markers are
in linkage disequilibrium, the paired null markers also
need to be correlated. We are currently working to
solve this important problem. Another approach for
reducing bias is to match the cases and controls in eth-
nicity. According to our simulations, we find that under
perfect matching and weak linkage disequilibrium, the
bias to the estimation of the interaction effect is small.
However, more study is needed in order to understand
the impact of the residual bias when the matching is
not perfect.
Conclusions
In this paper, the biases to the estimation of genetic
main and interaction effects are quantified and their
bounds are derived. We find that if there is environmen-
tal effect or interaction, the bias to the genetic main
effect cannot be ignored even cases and controls were
matched in ethnicity. The bias to the estimation of
interaction effect also has the same problem. The esti-
mated bound can be used to compute conservative p-
value for the association test. The computation of con-
servative p-value does not require the knowledge on the
number of subpopulations involved in the study or the
membership of each study subject. In real applications,
it is usually not clear that if there is PS or selection bias
or both. However, if appropriate information such as
the variation of genotype frequencies is known, we
always can compute the conservative p-value. If the con-
servative p-value is smaller than the designated signifi-
cance level, we can safely claim that the test is
significant regardless of the presence of PS/non-SRS.
Methods
Following the usual Bayesian argument, the disease-risk
model implies that
Pr

G = g, H = h|S = s, D =1

÷
Pr

G = g, H = h|S = s, D =0

= exp

μ  + αs + βg + γh + δgh

,
where
αs = α 
s +l o g

Pr(D =0 ,S = s)

Pr(D =1 ,S = s)

, s=
2,..., k. As a consequence,
Pr

G = g, H = h|D =1

= exp

μ  + βg + γh + δgh

×
k 
s=1
[Pr

G = g, H = h|S = s, D =0

×
P # (S = s|D =1 )exp(αs)].
On the other hand, the joint frequency distribution of
G and H in the control population is given by
Pr

G = g, H = h|D =0

=
k 
s=1
Pr

G = g, H = h|S = s, D =0

×
P # (S = s|D =0 ).
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Pr

G = g, H = h|S = s, D =1

÷
Pr

G = g, H = h|S = s, D =0

= exp

μ  + βg + γh + δgh

K∗ 
g, h

= exp{

μ  + μ∗
+

β + β∗
g+

γ + γ ∗
h +

δ + δ∗
gh}
Here, we define μ*=l o g { K
Δ
(0,0)},β∗ =l o g

K (1,0)
K (0,0)

, γ ∗ =l o g

K (0,1)
K (0,0)

and
δ∗ =l o g

K (1,1)K (0,0)
K (0,1)K (1,0)

,
whereK 
g, h

= K(g,h) ×
P(D =0 )
P(D =1 )
. Note that the
above results are derived using the expression of
exp(αs) =
P(G = H =0 |D =1 ,S = s)
P(G = H =0 |D =0 ,S = s)
=
P(D =1 |G = H =0 ,S = s)
P(D =0 |G = H =0 ,S = s)
×
P(S = s|D =0 )
P(S = s|D =1 )
×
P(D =0 )
P(D =1 )
.
Also note that we can express
exp(β∗)=
k 
s=1
Gs {DsDSs}ws
k 
s=1
Gsws
k 
s=1
{DsDSs}ws
, (3)
wherews = w∗
s/
K 
s=1
w∗
s and
w∗
s =P(G =0 ,H =0 |S = s,D =0 ) ×
P# (S = s|D =0 )
Define
UM
m(w)=wGMDMDSM +( 1− w)GmDmDSm
and
Vm
M(w)=wGM +( 1− w)Gm.
Simple algebra shows that there exists some constant
w* such that the bias is bounded above by
Um
M(w∗)
Um
M(w∗) × Vm
M(w∗)
≤ max
0≤w≤1
Um
M(w)
Um
M(w) × Vm
M(w)
=
√
G†D†DS†
√
G†D†DS† +1

2
√
G†D†DS† + G†

√
G†D†DS† + D†DS†

.
Here GM(Gm)i st h el a r g e s tv a l u eo fGs.DM, Dm, DSM,
and DSm are similarly defined. Also note that under
SRS, DSs = 1 and therefore according to the definition
of exp(δ*)we easily show that it is bounded above by (D
†
)
2 and bounded below by (D
† )
-2. However, under gen-
eral sampling design, the bias is expressed as
exp(δ∗)=
K 
s=1
ORsGsHsws
 
K 
s=1
Gsws
 
K 
s=1
Hsws
 
×
K 
s=1
Gsw  
s
K 
s=1
Hsw  
s
K 
s=1
ORsGsHsw  
s
,
(4)
where
w 
s =
DsDSsP# (S = s|D =0 )
k 
s =1
Ds DSs P# (S = s |D =0 )
and
w  
s =
P# (S = s|D =0 )
k 
s =1
P# (S = s |D =0 )
.B ya p p l y i n gt h es a m e
approach for deriving bounds for exp(b*), we also can
derive bounds for exp(δ*).
Additional material
Additional file 1: Biases and the true type I errors of the chi-square
tests. The file contains two tables showing the biases and true type I
errors of the chi-square tests when G
† = 3 and LD = (0,0) or LD = (0,0.5).
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